CanaFarma Hemp Products Corp.

OTC: CNFHF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#806 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ —GM —SS 18

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), balance-sheet leverage · ↓ disclosure history, market scale

Methodology →

Revenue TTM

-$513.4k

Rev growth YoY (TTM)

-130.3%

Net income (FY)

-$17.5M

Employees

Market cap

$19.6k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.8M$1.8M2020

Net income-$17.5M-$17.5M2020

Operating income-$10.1M-$10.1M2020

Total assets$6.8M$6.8M2020

Liabilities$6.9M$6.9M2020

Equity-$99.0k-$99.0k2020

Revenue trend

FY2018 – FY2020 · USD

FY18

$56.8k

FY19

$1.8M

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

CanaFarma Hemp Products Corp. booked $1.8M in FY2020 revenue, growing 3030% year over year — faster than 98% of Healthcare companies we track, at a -986.7% net margin.

Peers · Healthcare

Bhang Inc.——PrimeMD Inc——Encision Inc.——Parallel Industries Inc.——

Key facts

CEOPhil Klauder

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: CNFHF

Employees5

IPO date2021-04-01

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.